
Key measurements of U.S. CDER drug approvals in 2022
This statistic depicts the percentage of drugs approved by the U.S. Center for Drug Evaluation and Research (CDER) in 2022 that met select key measures. According to the data, 97 percent of all drugs approved in 2022 by CDER met the PDUFA goal date for approval and 54 percent of approved drugs were drugs for orphan diseases.